Exploring the frontier of microbiome biomarker discovery with artificial intelligence

被引：0
|
作者：
Liwen Xiao [1 ]
Fangqing Zhao [1 ,2 ]
机构：
[1] Institute of Zoology, Chinese Academy of Sciences
[2] Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study,University of Chinese Academy of
来源：
National Science Review | 2024年 / 11卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R37 [医学微生物学（病原细菌学、病原微生物学）]; TP18 [人工智能理论];
学科分类号：
100103 ; 100705 ; 081104 ; 0812 ; 0835 ; 1405 ;
摘要：
<正>The human microbiome refers to the entirety of bacteria, archaea, fungi and viruses in the human body, which are extensively linked to human health and play crucial roles in the occurrence and progression of various diseases, including cancers. Due to their feasible sampling and clear representation, components of the microbiome, particularly bacteria,
引用
收藏
页码：29 / 32
页数：4
相关论文
共 50 条
  • [21] Artificial Intelligence in Urology: The Final Frontier?
    Loughlin, Kevin R.
    UROLOGIC CLINICS OF NORTH AMERICA, 2024, 51 (01) : XI - XII
  • [22] Artificial intelligence: A new frontier in dermatology
    Sitaru, Sebastian
    Zink, Alexander
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (12) : 2199 - 2200
  • [23] Applications of artificial intelligence (AI) in ovarian cancer, pancreatic cancer, and image biomarker discovery
    Mikdadi, Dina
    O'Connell, Kyle A.
    Meacham, Philip J.
    Dugan, Madeleine A.
    Ojiere, Michael O.
    Carlson, Thaddeus B.
    Klenk, Juergen A.
    CANCER BIOMARKERS, 2022, 33 (02) : 173 - 184
  • [24] Conventional and artificial intelligence-based imaging for biomarker discovery in chronic liver disease
    Dana, Jeremy
    Venkatasamy, Aina
    Saviano, Antonio
    Lupberger, Joachim
    Hoshida, Yujin
    Vilgrain, Valerie
    Nahon, Pierre
    Reinhold, Caroline
    Gallix, Benoit
    Baumert, Thomas F.
    HEPATOLOGY INTERNATIONAL, 2022, 16 (03) : 509 - 522
  • [25] Artificial Intelligence-Assisted Drug and Biomarker Discovery for Glioblastoma: A Scoping Review of the Literature
    Conte, Luana
    Caruso, Gerardo
    Philip, Anil K.
    Cucci, Federico
    De Nunzio, Giorgio
    Cascio, Donato
    Caffo, Maria
    CANCERS, 2025, 17 (04)
  • [26] Conventional and artificial intelligence-based imaging for biomarker discovery in chronic liver disease
    Jérémy Dana
    Aïna Venkatasamy
    Antonio Saviano
    Joachim Lupberger
    Yujin Hoshida
    Valérie Vilgrain
    Pierre Nahon
    Caroline Reinhold
    Benoit Gallix
    Thomas F. Baumert
    Hepatology International, 2022, 16 : 509 - 522
  • [27] Artificial Intelligence for Drug Discovery
    Tang, Jian
    Wang, Fei
    Cheng, Feixiong
    KDD '21: PROCEEDINGS OF THE 27TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, 2021, : 4074 - 4075
  • [28] Artificial Intelligence and Antibiotic Discovery
    David, Liliana
    Brata, Anca Monica
    Mogosan, Cristina
    Pop, Cristina
    Czako, Zoltan
    Muresan, Lucian
    Ismaiel, Abdulrahman
    Dumitrascu, Dinu Iuliu
    Leucuta, Daniel Corneliu
    Stanculete, Mihaela Fadygas
    Iaru, Irina
    Popa, Stefan Lucian
    ANTIBIOTICS-BASEL, 2021, 10 (11):
  • [29] Artificial intelligence for materials discovery
    Carla P. Gomes
    Bart Selman
    John M. Gregoire
    MRS Bulletin, 2019, 44 : 538 - 544
  • [30] Discovery in an age of artificial intelligence
    Luther, Judy
    LEARNED PUBLISHING, 2016, 29 (02) : 75 - 76
12345